Quick look at REIT’s.

442805746_6d0b948a04_oFor older people searching for good safe yields, it is hard to beat certain REIT’s. Many even pay dividends monthly for income investors, great for using DRIP.

Real estate investment trusts (REIT’s) own and usually operate income producing real estate. This isn’t just commercial and residential real estate. There are REIT’s that specialize in healthcare and data centers. Ratios you want to consider especially with REIT’s are Debt/Equity ratio and Payout ratio (% of earnings paid out as dividends). Payout ratios of over 100% mean the company is paying out more in dividends than it’s earnings. The main point to get out of this post is to know that, for the coming years, it would be smart to avoid just about all the mall and retail REIT’s, as Amazon is increasingly winning the fight for shoppers income. Healthcare, Office and Data Centers are definitely here to stay, compared to the mall/retail REIT’s.

Disclaimer: I own shares in NWH.UN. You are taking a risk buying stocks no matter how informed you feel that you are. I am not responsible for your decisions.

 

Biotechnology Stocks to Look at.

There is no doubt that Biotech’s importance in the future is massive, but that doesn’t mean betting the farm on a couple securities. Nevertheless, having some exposure to promising small cap and blue chip Biotech companies is definitely meanwhile for any risk-taking value investor.

1 year chart of NASDAQ Biotechnology Index
1 year chart of NASDAQ Biotechnology Index – Yahoo Finance

As we can see the Biotech sector has had a rough past year, with a 52 week high and low of 4165 and 2552, as shown by the yellow dots. Last year, lots of hype had pushed many biotech securities to very high and usually unjustified P/E values. A sell-off starting ~10 months ago makes sense.

 

In the aftermath however, there are great deals to find at very low valuations. Take Gilead for example. Trading with a market cap of 119.27B at a very low 7.4 P/E, the value is there.

Gilead Science 3 month chat marketwatch.com
Gilead Science 3 month chat marketwatch.com

Look deeper, and you will see the reason is the slow pipeline Gilead has going for it. There is good news though. The stock is undervalued with great potential, given the size of the company and all the great acquisition targets a blue chip Biotech firm has out there. That would be my “less risky” biotech  value play. A much riskier play with higher upside is Palatin Technologies. It’s primary drug it is working on is Bremelanotide (Phase 3 Preliminary Results coming on Q3 2016). You may have heard of it as the “female viagra”.  A recent study in part funded by Palatin Technologies cleared concerns that Bremelanotide interacted severely enough with ethanol, which news outlets reported that people taking this drug wouldn’t be allowed any alcohol. What many people don’t know is that this new study showed no clinically significant relationship. It is indeed safe to ingest ethanol while on this drug. This study I believe will definitely help Bremelanotide get its thumbs up from the FDA (Deadline for Phase 3 top-line data is 9/30/2016). Palatin Technologies has 23 million in investments and cash, and is burning 11 million per year, giving them enough time to get this drug to market. Definitely a stock to keep on your radar.

Thank you for reading my blog, don’t hesitate to leave feedback :). Tomorrow I will talk about REIT’s, the cheap way to own a piece of “liquid” real estate.

Cheers fellas!

2016 And Beyond, Your Guide to Get Started Investing

Welcome to my investment analysis and advice blog. I’m not going to offer all of the same advice you hear everywhere, because a lot of that advice is boring (while pragmatic and not to be ignored).

Let us begin briefly with essentials you need to know reading this blog. You will only have to go through this once, and then we can get to interesting stuff.

P/E – Price/Earnings, A measure of a company’s current share price relative to its per share earnings.

EPS – Earnings per share. Net income earned on each share of a company’s common stock. Additionally it is calculated as (Net Profit – Dividends on Preferred Stock)/ Average Outstanding Shares. EPS going up more than expected = good, EPS lower than expected = VERY bad.

Debt/Equity Ratio. What if the stock you are looking at is borrowing too much? Debt/Equity Ratio gives you an easy way of looking at that. Calculated as (Long Term Debt + Short Term Debt)/ Book Value of Shareholders Equity. Usually its between 0.1 and 3.0, 0.1 means it has a large safety margin when it comes to interest rates rising, and 3.0 meaning the opposite.

Market Capitalization – Market Cap. Market Cap is the size of the company. How big the waves it splashes are in its market and the global market. It is calculated as following: Current Share price * Shares outstanding. Terms like Small-cap and Blue chip are referring to Market Cap.

Today I won’t really point to any stocks I consider worth owning in anyone’s portfolio. That will come in my next post. Instead what is best is that you understand what each investing strategy brings to the table, and infer the one you think will work best for you.

 

Investing Strategies.

 

Style Investing

Style Investing, put simply is looking at underlying characteristics in common to certain types of investments. For example, choosing securities from broad categories of securities like Small-cap or Tech. This is useful to anyone who lacks the money to diversify by buying a ton of individual stocks, as you can give your portfolio exposure to a broad range of markets. Value Investing, a very sane approach to investing belongs as a sub-style within Style Investing.

Index Investing

Don’t be persuaded to believe Index Investing is a “be all and end all” approach, or that it’s de-facto the safer way to invest in the stock market. This isn’t accurate as some index fund are leveraged, like UWTI, and easily and very commonly swing 5-15% one day then shoot down 5-15% the next day. You can also play it safe (relatively) with something like the SPDR S&P 500 ETF Trust, which seeks to replicate the S&P 500 index. Adjusted for inflation, the S&P 500 has returned ~7% yearly on average since it’s inception. You could definitely do worse. You would be performing on-par with the market. Consistently (5+ years) beating the market is very difficult and is not done by many. But it’s definitely possible.

I made this blog not to teach people how to perform on par with the market, but how to, as an active investor, see greater returns. If you read this entire post start to finish, congratulations, you probably have the dedication to do quite well at anything.

In my next post right here I go more into depth in the first sector I wanted to talk about, Biotechnology.

I strongly recommend Benjamin Graham’s (Warren Buffet’s Mentor) book Intelligent Investor. You can order it on Amazon here